BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6980966)

  • 1. Lymphocyte abnormality associated with HLA-B8 in healthy young adults.
    McCombs CC; Michalski JP
    J Exp Med; 1982 Sep; 156(3):936-41. PubMed ID: 6980966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.
    Amer A; Singh G; Darke C; Dolby AE
    Tissue Antigens; 1986 Oct; 28(4):193-8. PubMed ID: 3492778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.
    Hashimoto S; McCombs CC; Michalski JP
    Clin Exp Immunol; 1989 Jun; 76(3):317-23. PubMed ID: 2787712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B8/DR3 phenotype and the primary immune response.
    Kallenberg CG; Klaassen RJ; Beelen JM; The TH
    Clin Immunol Immunopathol; 1985 Jan; 34(1):135-40. PubMed ID: 3871182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B8, DR3 antigens and production of human leucocyte migration inhibitory factor (LIF) by mononuclear cells stimulated with concanavalin A (Con A).
    Caruso C; Bellina L
    Tissue Antigens; 1983 Aug; 22(2):167-9. PubMed ID: 6353661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis.
    Hall RP; Leiserson WM; Chused TM; Lawley TJ
    J Invest Dermatol; 1984 Mar; 82(3):231-4. PubMed ID: 6230405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive effect of Fusarium mycotoxin as a function of HLA antigens.
    Berek L; Petri IB; Mesterházy A; Téren J
    Acta Microbiol Immunol Hung; 2002; 49(1):99-104. PubMed ID: 12073830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates.
    McCombs CC; Michalski JP; deShazo R; Bozelka B; Lane JT
    Clin Immunol Immunopathol; 1986 Apr; 39(1):112-20. PubMed ID: 3485020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.
    Modica MA; Cammarata G; Caruso C
    J Immunogenet; 1990; 17(1-2):101-7. PubMed ID: 2212697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2.
    Candore G; Colucci AT; Modica MA; Caruso C
    Immunopharmacol Immunotoxicol; 1991; 13(4):551-61. PubMed ID: 1774436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte activation by a gluten fraction, glyc-gli. Studies of adult coeliac patients and healthy controls.
    Scott H; Fausa O; Thorsby E
    Scand J Immunol; 1983 Sep; 18(3):185-91. PubMed ID: 6604938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.
    Candore G; Cigna D; Todaro M; De Maria R; Stassi G; Giordano C; Caruso C
    Hum Immunol; 1995 Apr; 42(4):289-94. PubMed ID: 7558912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1.
    Hashimoto S; Michalski JP; Berman MA; McCombs C
    Clin Exp Immunol; 1990 Feb; 79(2):227-32. PubMed ID: 2311300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin genes, HLA-B8/DR3, and immune responsiveness to primary immunogen and mitogens in normal subjects.
    Kallenberg CG; Klaassen RJ; Westra J; Beelen JM; Ockhuizen T
    Clin Immunol Immunopathol; 1988 Jun; 47(3):333-42. PubMed ID: 3259481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals.
    Modica MA; Zambito AM; Candore G; Caruso C
    Immunobiology; 1990 Nov; 181(4-5):257-66. PubMed ID: 2129202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
    Ulmer AJ; Scholz W; Ernst M; Flad HD
    Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HL-A antigen in Sjögren's syndrome.
    Nahir AM; Scharf Y; Gidoni O; Koren L; Zonis S; Barzilai A
    Ann Ophthalmol; 1980 Sep; 12(9):1084-6. PubMed ID: 6985419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.
    Stassi G; Todaro M; De Maria R; Candore G; Cigna D; Caruso C; Galluzzo A; Giordano C
    Hum Immunol; 1997 Jun; 55(1):39-45. PubMed ID: 9328788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
    Toews GB; Vial WC; Dunn MM; Guzzetta P; Nunez G; Stastny P; Lipscomb MF
    J Immunol; 1984 Jan; 132(1):181-6. PubMed ID: 6228577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.